Altered T Cell Ligands Derived from a Major House Dust Mite Allergen Enhance IFN-γ but Not IL-4 Production by Human CD4+ T Cells

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2160-2165

  Tsitoura, Daphne C ^a   Verhoef, Adrienne ^a   Gelder, Colin M ^a   O'Hehir, Robyn E ^a   Lamb, Jonathan R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GAMMA INTERFERON; GLYCOPROTEIN; HOUSE DUST ALLERGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CLONE; CHEMISTRY; DRUG EFFECT; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MITE; MOLECULAR GENETICS; PHYSIOLOGY; SYNTHESIS; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; GLYCOPROTEINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MITES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS; TH2 CELLS;

EID: 0030239669     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. O'Hehir, R. E., V. Bal, D. Quint, R. Moqbel, A. B. Kay, E. D. Zanders, and J. R. 1989. An in vitro model of allergen dependent IgE synthesis by human B cells: comparison of the response of an atopic and non-atopic individual to Dermatophagoides spp. Immunology 66:499.
2. + T lymphocytes in atopic patients. J. Immunol. 144:4651.
3. Parronchi, P., D. Macchia, M.-P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. Ansari, and S. Romagnani. 1991. Allergen and bacterial antigen specific T cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88:4538.
4. Varney, V. A., Q. A. Hamid, M. Gaga, S. Ying, A. J. Frew, A. B. Kay, and S. R. Durham. 1993. Influence of grass pollen immunotherapy on cellular infiltrate and cytokine mRNA expression during allergen induced late phase cutaneous responses. J. Clin. Invest. 192:644.
5. O'Hehir, R. E., R. D. Garman, J. L. Greenstein, and J. R. Lamb. 1991. The specificity and regulation of T cell responsiveness to allergen. Annu. Rev. Immunol. 9:76.
6. + T cells. Immunol. Rev. 123:209.
7. Street, N. F., J. H. Schumacher, T. A. T. Fong, H. Bass, D. F. Fiorentino, J. A. Leverah, and T. R. Mosmann. 1990. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J. Immunol. 144:1629.
8. Punnonen, J., G. Aversa, B. G. Cocks, A. N. J. McKenzie, S. Menon, G. Zurawaski, R. de Waal Malefyt, and J. E. de Vries. 1993. Interleukin 13 induced interleukin 4 dependent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90:3730.
9. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
10. Pene, J. R. F., F. Briere, I. Chretein, J. Y. Bonnefoy, H. Spits, T. Yokota, N. Arai, K.-I. Arai, Banchereau, and J. E. de Vries. 1988. IgE production by normal human B lymphocytes is induced by interleukin (IL)-4 and suppressed by interferon (IFN)-γ and -α, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85:6880.
11. Babbitt, B. P., P. M. Allen, G. Matsueda, E. Haber, and E. R. Unanue. 1985. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:359.
12. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
13. Evavold, B. D., J. Sloan-Lancaster, B. L. Hsu, and P. M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
14. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production and proliferation by an altered T cell receptor ligand. Science 252:1308.
15. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T cell anergy by altered T cell receptor ligand on live antigen presented cells. Nature 363:156.
16. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195.
17. Pfeifler, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomley. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
18. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand related differences in T cell receptor dependent intracellular signaling. J. Exp. Med. 177:1047.
19. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
20. Verhoef, A., J. A. Higgins, C. J. Thorpe, S. G. E. Marsh, J. D. Hayball, J. R. Lamb, and O'Hehir. 1993. Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp: identification of HLA-DR and -DQ restricted T cell epitopes. Int. Immunol. 5:1589.
21. Wraith, D. C., B. Bruun, and P. J. Fairchild. 1992. Cross reactive recognition of an encephalatogenic epitope. J. Immunol. 149:3765.
22. H0 cell effector function. Immunology 85:447.
23. + T cell subsets. Clin. Exp. Allergy 25:839.
24. Kuchroo, V. K., J. M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R. Sobel, and M. Lees. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:3326.
25. + T cell targeted immunomodulation and the therapy of allergic disease. Clin. Immunol. Immunopathol. 73:1.
26. Hammer, J., E. Bono, F. Gallazzi, C. Belinis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility class II peptide interactions based on peptide side chain scanning. J. Exp. Med. 180:2353.
27. Hammer, J., P. Valsasnini, D. Tolba, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific HLA-DR binding peptides. Cell 74:197.
28. Rammensee, H. G., T. Friede, and S. Stevanovie. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
29. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
30. Murray, J. S., C. Pfeiffer, I. Madri, and K. Bottomley. 1992. MHC control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 22:559.
31. Gajewski, T. F., D. W. Lancki, R. Stack, and F. W. Fitch. 1994. "Anergy" of Th0 helper T lymphocytes induces downregulation of Th1 characteristics and a transition to a Th2-like phenotype. J. Exp. Med. 179:481.
32. Jutel, M. P., W. J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U. R. Muller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154:418.